Table 1.
Demographic and neuropsychological performances in patients with AOS and healthy controls (M ± SD)
| Items | Patients with AOS | Healthy controls | T/x2 | P value |
|---|---|---|---|---|
| Number of participants | 71 | 53 | ||
| Gender (male/female) | 40/31 | 23/30 | 2.034 | 0.154 |
| Age (years) | 16.11 ± 1.38 | 15.80 ± 0.87 | 1.649 | 0.102 |
| Educational year | 9.87 ± 1.47 | 10.47 ± 0.82 | −1.688 | 0.094 |
| MoCA | 27.67 ± 1.99 | 28.6 ± 1.49 | −2.495 | 0.015* |
| Stroop Color | 17.02 ± 5.39 | 12.25 ± 2,78 | 6700 | < 0.001*** |
| Stroop Word | 20.30 ± 7.02 | 14.68 ± 3.90 | 5940 | < 0.001*** |
| Stroop Color&Word | 33.16 ± 13.46 | 26.34 ± 9.05 | 3.546 | 0.001*** |
| DS-Forward | 7.96 ± 0.25 | 7.96 ± 0.18 | −0.069 | 0.945 |
| DS-Backward | 5.45 ± 1.15 | 6.31 ± 0.84 | −4.677 | < 0.001*** |
| PANSS-P | 13.81 ± 6.27 | |||
| PANSS-N | 13.44 ± 6.45 | |||
| PANSS-T | 54.81 ± 14.77 | |||
| CPZeq of total antipsychotic drugs (mg/day) | 441.55 ± 115.76 |
Note: MoCA Montreal Cognitive Assessment; Stroop Stroop Color Word Tasks; PANSS Positive and Negative Syndrome Scale. PANSS - P PANSS Positive Subscale Score; PANSS - N PANSS Negative Subscale Score; PANSS - T PANSS Total Score; DS The Digital Span Test, CPZ - eq Chlorpromazine - equivalent.* p < 0.05, *** p < 0.001